BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 545.18B
Enterprise Value 347.4B
Trailing P/E 10.07
Forward P/E 17.63
PEG Ratio (5 yr expected) 11.15
Price/Sales (ttm)3.27
Price/Book (mrq)3.27
Enterprise Value/Revenue 33.43
Enterprise Value/EBITDA 66.71

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 33.79%
Operating Margin (ttm)46.80%

Management Effectiveness

Return on Assets (ttm)15.38%
Return on Equity (ttm)33.82%

Income Statement

Revenue (ttm)13.81B
Revenue Per Share (ttm)68.65
Quarterly Revenue Growth (yoy)11.50%
Gross Profit (ttm)11.64B
EBITDA 7.07B
Net Income Avi to Common (ttm)4.67B
Diluted EPS (ttm)23.14
Quarterly Earnings Growth (yoy)20.10%

Balance Sheet

Total Cash (mrq)3.91B
Total Cash Per Share (mrq)20.16
Total Debt (mrq)6.38B
Total Debt/Equity (mrq)46.15
Current Ratio (mrq)2.84
Book Value Per Share (mrq)71.33

Cash Flow Statement

Operating Cash Flow (ttm)6.19B
Levered Free Cash Flow (ttm)3.13B

Trading Information

Stock Price History

Beta (3Y Monthly) 1.62
52-Week Change 3-20.63%
S&P500 52-Week Change 34.60%
52 Week High 3388.67
52 Week Low 3216.12
50-Day Moving Average 3228.56
200-Day Moving Average 3280.32

Share Statistics

Avg Vol (3 month) 32.59M
Avg Vol (10 day) 31.36M
Shares Outstanding 5193.89M
Float 193.57M
% Held by Insiders 10.47%
% Held by Institutions 193.42%
Shares Short (May 31, 2019) 43.83M
Short Ratio (May 31, 2019) 42.04
Short % of Float (May 31, 2019) 41.98%
Short % of Shares Outstanding (May 31, 2019) 41.97%
Shares Short (prior month Apr 30, 2019) 43.96M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/3
Last Split Date 3Jan 18, 2001